The Valley Desk

NCT02614183 · Interventional trial

Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study

Overall registry status Completed

Phase 3

Conditions Migraine

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov